Incyte Corp | 76.5600 / +0.07% |
Date/Time | 05/26 / 18:29 |
Chg. / Chg.(%) | 0.0500 / +0.07% |
Bid | 76.5400 / 100 |
Ask | 76.6100 / 100 |
Open | 76.8900 |
Previous Close | 76.5100 |
High | 77.6200 |
Low | 76.3100 |
Volume [USD] | 12,744,587.6189 |
Volume [Units] | 264,897 |
Price fixings | 990 |
ISIN | US45337C1027 |
Security | INCY |
Exchange | NASDAQ |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 76.5600 | ![]() |
264,897 |
Cboe US | 76.50 | ![]() |
17,042 |
IEX | 76.46 | ![]() |
13,964 |
London Domes.. | 76.88 | ![]() |
342 |
TradeGate | 71.920 | ![]() |
279 |
Hannover | 72.06 | ![]() |
0 |
Frankfurt | 71.4700 | ![]() |
0 |
München | 71.48 | ![]() |
0 |
Düsseldorf | 71.97 | ![]() |
0 |
Berlin | 71.43 | ![]() |
0 |
Lang & Schwa.. | 71.39 | ![]() |
|
Stuttgart | 71.700 | ![]() |
|
Quotrix | 72.3700 | ![]() |
|
gettex | 71.510 | ![]() |
|
Mexico | 1,492.00 | ![]() |
9 |
News
- RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation Annual Scientific Symposium
03/23/2022 / 21:01 - GlobeNewswire - STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations
03/14/2022 / 21:05 - GlobeNewswire - Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus Retifanlimab as Investigational First Line Therapy for Patients With Advanced Pancreatic Cancer
03/01/2022 / 13:55 - GlobeNewswire - Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Update
02/28/2022 / 22:36 - GlobeNewswire - MacroGenics Provides Update on Corporate Progress and 2021 Financial Results
02/24/2022 / 22:01 - GlobeNewswire